Interpretable Machine Learning Model for Predicting the Prognosis of Guillain-Barré Syndrome Patients

被引:1
|
作者
Guo, Junshuang [1 ,2 ]
Zhang, Ruike [1 ]
Dong, Ruirui [1 ]
Yang, Fan [1 ]
Wang, Yating [1 ]
Miao, Wang [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Neurointens Care Unit, Zhengzhou 450000, Henan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Dept Immunol, Changsha, Hunan, Peoples R China
关键词
Guillain-Barr & eacute; syndrome; machine learning; prognosis; SHAP;
D O I
10.2147/JIR.S471626
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Machine learning (ML) is increasingly used in medical predictive modeling, but there are no studies applying ML to Materials and Methods: The medical records of 223 patients with GBS were analyzed to construct predictive models that affect patient prognosis. Least Absolute Shrinkage and Selection Operator (LASSO) was used to filter the variables. Decision Trees (DT), Light Gradient Boosting Machine (LGBM) and Logistic Regression (LR) were used to construct predictive models. Clinical data from 55 GBS patients were used to validate the model. SHapley additive explanation (SHAP) analysis was used to explain the model. Single sample gene set enrichment analysis (ssGSEA) was used for immune cell infiltration analysis. Results: The AUCs (area under the curves) of the 8 ML algorithms including DT, RF, XGBoost, KNN, NB, NN, LGBM and LR were as follows: 0.75, 0.896 0.874, 0.666, 0.742, 0.765, 0.869 and 0.744. The accuracy of XGBoost (0.852) was the highest, followed by LGBM (0.803) and RF (0.758), with F1 index of 0.832, 0.794, and 0.667, respectively. The results of the validation set data analysis showed AUCs of 0.839, 0.919, and 0.733 for RF, XGBoost, and LGBM, respectively. SHAP analysis showed that the SHAP values of blood neutrophil/lymphocyte ratio (NLR), age, mechanical ventilation, hyporeflexia and abnormal glossopharyngeal vagus nerve were 0.821, 0.645, 0.517, 0.401 and 0.109, respectively. Conclusion: The combination of NLR, age, mechanical ventilation, hyporeflexia and abnormal glossopharyngeal vagus used to predict short-term prognosis in patients with GBS has a good predictive value.
引用
收藏
页码:5901 / 5913
页数:13
相关论文
共 50 条
  • [21] Guillain-Barr, syndrome in children
    Incecik, Faruk
    Herguner, M. Ozlem
    Altunbasak, Sakir
    NEUROLOGICAL SCIENCES, 2011, 32 (03) : 381 - 385
  • [22] Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome
    Jingyan Yang
    Linpei Jia
    Critical Care, 19
  • [23] Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome
    Xiujuan Wu
    Chunrong Li
    Bing Zhang
    Donghui Shen
    Ting Li
    Kangding Liu
    Hong-Liang Zhang
    Critical Care, 19
  • [24] The role of cytokines in Guillain-Barr, syndrome
    Lu, Ming-Ou
    Zhu, Jie
    JOURNAL OF NEUROLOGY, 2011, 258 (04) : 533 - 548
  • [25] Critical Care in Guillain-Barré Syndrome
    Rao, G. S. Umamaheswara
    JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE, 2024, 11 (02) : 77 - 85
  • [26] Respiratory dysfunction in guillain-barré syndrome
    David Orlikowski
    Hélène Prigent
    Tarek Sharshar
    Frédéric Lofaso
    Jean Claude Raphael
    Neurocritical Care, 2004, 1 : 415 - 422
  • [27] Guillain-Barr, syndrome and ulceroglandular tularemia
    Ylipalosaari, P.
    Ala-Kokko, T. I.
    Tuominen, H.
    Syrjala, H.
    INFECTION, 2013, 41 (04) : 881 - 883
  • [28] Intravenous immunoglobulin and guillain-barré syndrome
    Michal Harel
    Yehuda Shoenfeld
    Clinical Reviews in Allergy & Immunology, 2005, 29 : 281 - 287
  • [29] Outcome in childhood Guillain-Barré syndrome
    Veena Kalra
    Naveen Sankhyan
    Suvasini Sharma
    Sheffali Gulati
    Rama Choudhry
    Benu Dhawan
    The Indian Journal of Pediatrics, 2009, 76 : 795 - 799
  • [30] Vestibular impairment in Guillain-Barré syndrome
    Akdal, Gulden
    Kocoglu, Koray
    Ala, Rahmi Tumay
    Tanriverdizade, Tural
    Ozcelik, Pinar
    Sengun, Ihsan Sukru
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 (04) : 677 - 678